Evidence map›Paper›PMID 39292563›Full record

ArticleGut microbes

Gut microbiota-derived butyrate selectively interferes with growth of carbapenem-resistant

Eva Happ, Kora Schulze, Zinia Afrin, Sabrina Woltemate, Pia Görner, Stefan Ziesing, Dirk Schlüter, Robert Geffers, Volker Winstel, Marius Vital

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Gut microbes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Eva HappInstitute of Medical Microbiology and Hospital Epidemiology, Hannover Medical School, Hannover, Germany.
Kora SchulzeInstitute of Medical Microbiology and Hospital Epidemiology, Hannover Medical School, Hannover, Germany.
Zinia AfrinInstitute of Medical Microbiology and Hospital Epidemiology, Hannover Medical School, Hannover, Germany.
Sabrina WoltemateInstitute of Medical Microbiology and Hospital Epidemiology, Hannover Medical School, Hannover, Germany.
Pia GörnerInstitute of Medical Microbiology and Hospital Epidemiology, Hannover Medical School, Hannover, Germany.
Stefan ZiesingInstitute of Medical Microbiology and Hospital Epidemiology, Hannover Medical School, Hannover, Germany.
Dirk SchlüterInstitute of Medical Microbiology and Hospital Epidemiology, Hannover Medical School, Hannover, Germany.
Robert GeffersGenomics Research Group, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Volker WinstelInstitute of Medical Microbiology and Hospital Epidemiology, Hannover Medical School, Hannover, Germany.
Marius VitalInstitute of Medical Microbiology and Hospital Epidemiology, Hannover Medical School, Hannover, Germany.ORCID 0000-0003-4185-3475

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated consequences of resistance acquisition in

Indexed as

ButyratesEscherichia coliGastrointestinal MicrobiomeAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenem-Resistant EnterobacteriaceaeCarbapenemsEscherichia coli InfectionsEscherichia coli ProteinsHumansPorinsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesButyratescarbapenemaseCarbapenemsEscherichia coli ProteinsPorinsanaerobic cultivationAntibiotic resistancebacterial physiologybutyrateEscherichia coligene expressiongut microbiota

Identifiers

PMID39292563
PMCPMC11529417

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.